Asgard Therapeutics

Lund, Sweden

Asgard Therapeutics is a Biotechnology Company.

$32.6M raised

Mar 2024

Series A

Biotechnology Therapeutics

Top Investors

Novo HoldingsBoehringer Ingelheim Venture FundJohnson & Johnson Innovation – JJDCIndustrifondenLU Innovation

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Asgard Therapeutics

How much funding has Asgard Therapeutics raised?

Asgard Therapeutics has raised $32.6M in total funding. The most recent round was Series A. The last funding was announced in March 2024.

Who are Asgard Therapeutics's investors?

Asgard Therapeutics's investors include Novo Holdings, Boehringer Ingelheim Venture Fund, Johnson & Johnson Innovation – JJDC, Industrifonden, LU Innovation.

Where is Asgard Therapeutics headquartered?

Asgard Therapeutics is headquartered in Lund, Sweden.

What does Asgard Therapeutics do?

Asgard Therapeutics is a Biotechnology Company.

What stage is Asgard Therapeutics at?

Asgard Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2024.

MLA

"Asgard Therapeutics — Funding & Investors." VCBacked, March 14, 2024, https://www.vcbacked.co/company/asgard-therapeutics. Accessed June 7, 2026.

APA

VCBacked. (2024). Asgard Therapeutics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/asgard-therapeutics

Wikipedia (cite web)

{{cite web |title=Asgard Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/asgard-therapeutics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2024.